Commercialising a novel discovery in the field of medicine requires a critical path analysis and knowledge of how to achieve specific studies on this critical path.

Discovery 2 Medicine (D2M) provides industrial and academic expertise through an expert review panel and gives advice and mechanisms to take projects forward. Discovery 2 Medicine, having identified a real need for this kind of service, has assisted a significant number of projects and companies.

The Board acts as a team and its breadth of experience means that it is thus capable of contributing to each individual problem identified by its customers. This makes Discovery 2 Medicine’s offering unique.